Krystal Biotech, Inc.
DE ˙ DB ˙ US5011471027
€ 257,90 ↓ -1.10 (-0.42%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:4KB / Krystal Biotech, Inc.
InstitutionS Squared Technology, LLC
Latest Disclosed Ownership86,215 shares
Latest Disclosed Value $ 22,271,059
S Squared Technology, LLC reports 10.39% decrease in ownership of 4KB / Krystal Biotech, Inc.

On May 15, 2026 - S Squared Technology, LLC filed a 13F-HR/A form disclosing ownership of 86,215 shares of Krystal Biotech, Inc. (DE:4KB) valued at $18,553,468 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 96,215 shares of Krystal Biotech, Inc.. This represents a change in shares of -10.39% during the quarter. The current value of the position is $22,234,848 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 86,215 -10,000 -10.39 22,271 -6.11 8.4294
2026-05-14 2026-03-31 13F KRYSTAL BIOTECH COM 501147102 86,215 -10,000 22,271 8.4294
2026-02-13 2025-12-31 13F KRYSTAL BIOTECH COM 501147102 96,215 -13,000 -11.90 23,721 23.04 9.1854
2025-11-14 2025-09-30 13F KRYSTAL BIOTECH COM 501147102 109,215 0 0.00 19,280 28.42 7.3296
2025-08-07 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 109,215 12,000 12.34 15,013 -14.35 6.3258
2025-05-16 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 97,215 2,000 2.10 17,528 17.50 8.9681
2025-02-13 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 95,215 20,000 26.59 14,916 8.95 6.1969
2024-11-14 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 75,215 -10,000 -11.74 13,691 -12.51 5.8404
2024-08-14 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 85,215 -5,000 -5.54 15,649 -2.51 6.9060
2024-05-15 2024-03-31 13F KRYSTAL BIOTECH COM 501147102 90,215 -20,000 -18.15 16,052 17.39 7.3703
2024-02-13 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 110,215 2,000 1.85 13,673 8.93 6.6371
2023-11-13 2023-09-30 13F KRYSTAL BIOTECH COM 501147102 108,215 0 0.00 12,553 -1.20 6.7726
2023-08-11 2023-06-30 13F KRYSTAL BIOTECH COM 501147102 108,215 0 0.00 12,704 46.65 6.2867
2023-05-12 2023-03-31 13F KRYSTAL BIOTECH COM 501147102 108,215 0 0.00 8,664 1.06 5.1448
2023-02-14 2022-12-31 13F KRYSTAL BIOTECH COM 501147102 108,215 0 0.00 8,573 13.64 5.8022
2022-11-14 2022-09-30 13F KRYSTAL BIOTECH COM 501147102 108,215 0 0.00 7,543 6.16 5.5189
2022-08-12 2022-06-30 13F KRYSTAL BIOTECH COM 501147102 108,215 0 0.00 7,105 -1.33 4.9195
2022-05-13 2022-03-31 13F KRYSTAL BIOTECH COM 501147102 108,215 13,000 13.65 7,201 8.12 3.5947
2022-02-14 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 95,215 10,000 11.74 6,660 49.70 2.9806
2021-11-12 2021-09-30 13F KRYSTAL BIOTECH COM 501147102 85,215 0 0.00 4,449 -23.23 2.0170
2021-08-13 2021-06-30 13F KRYSTAL BIOTECH COM 501147102 85,215 0 0.00 5,795 -11.73 2.6227
2021-05-13 2021-03-31 13F KRYSTAL BIOTECH COM 501147102 85,215 0 0.00 6,565 28.40 3.1040
2021-02-12 2020-12-31 13F KRYSTAL BIOTECH COM 501147102 85,215 5,000 6.23 5,113 48.07 2.9324
2020-11-13 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 80,215 10,000 14.24 3,453 18.74 2.5669
2020-08-13 2020-06-30 13F KRYSTAL BIOTECH COM 501147102 70,215 10,000 16.61 2,908 11.67 2.2845
2020-05-14 2020-03-31 13F KRYSTAL BIOTECH COM 501147102 60,215 0 0.00 2,604 -21.92 2.5269
2020-02-14 2019-12-31 13F KRYSTAL BIOTECH COM 501147102 60,215 -7,318 -10.84 3,335 42.22 2.7385
2019-11-14 2019-09-30 13F KRYSTAL BIOTECH COM 501147102 67,533 0 0.00 2,345 -13.79 2.0662
2019-08-12 2019-06-30 13F KRYSTAL BIOTECH COM 501147102 67,533 -1,367 -1.98 2,720 19.98 2.0295
2019-05-14 2019-03-31 13F KRYSTAL BIOTECH COM 501147102 68,900 -5,000 -6.77 2,267 47.59 1.7515
2019-02-13 2018-12-31 13F KRYSTAL BIOTECH COM 501147102 73,900 20,000 37.11 1,536 62.03 1.3536
2018-11-13 2018-09-30 13F KRYSTAL BIOTECH COM 501147102 53,900 53,900 948 0.7442
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.